(NAFLD) Completed Phase 2 Trials for VK-2809 (DB15137)

Also known as: NAFLD

IndicationStatusPhase
DBCOND0039962 ((NAFLD))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02927184Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver DiseaseTreatment